Roberto Cauda to Male
This is a "connection" page, showing publications Roberto Cauda has written about Male.
Connection Strength
0.097
-
Psychopathological profile in COVID-19 patients including healthcare workers: the implications. Eur Rev Med Pharmacol Sci. 2020 11; 24(22):11964-11970.
Score: 0.012
-
A pilot experience of common European infectious diseases curriculum for medical students: the IDEAL summer school. Future Microbiol. 2019 03; 14:369-372.
Score: 0.011
-
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother. 2008 Nov; 62(5):1130-7.
Score: 0.005
-
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering. J Healthc Eng. 2021; 2021:5556207.
Score: 0.003
-
Psychological distress during the initial stage of the COVID-19 pandemic in an Italian population living with HIV: an online survey. Infez Med. 2021 Mar 01; 29(1):54-64.
Score: 0.003
-
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug; 121(8):1054-1065.
Score: 0.003
-
Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals. AIDS. 2000 Dec 22; 14(18):2948-9.
Score: 0.003
-
People Living with HIV in the COVID-19 Era: A Case Report. AIDS Res Hum Retroviruses. 2021 04; 37(4):253-254.
Score: 0.003
-
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic. HIV Med. 2021 01; 22(1):e3-e4.
Score: 0.003
-
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 10 30; 30(11):1899-1913.
Score: 0.003
-
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab. Infection. 2020 Oct; 48(5):767-771.
Score: 0.003
-
Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line. Int J Antimicrob Agents. 2020 Aug; 56(2):106017.
Score: 0.003
-
Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum ß-lactamase-producing Enterobacteriaceae infections. Int J Antimicrob Agents. 2019 Jul; 54(1):49-54.
Score: 0.003
-
Liver fibrosis is associated with cognitive impairment in people living with HIV. Infection. 2019 Aug; 47(4):589-593.
Score: 0.003
-
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. J Antimicrob Chemother. 2018 07 01; 73(7):1955-1964.
Score: 0.003
-
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy. J Antimicrob Chemother. 2018 07 01; 73(7):1949-1954.
Score: 0.003
-
Systematic clinical management of patients with candidemia improves survival. J Infect. 2018 08; 77(2):145-150.
Score: 0.003
-
Procalcitonin is useful in driving the choice of early antibiotic treatment in patients with bloodstream infections. Eur Rev Med Pharmacol Sci. 2018 05; 22(10):3130-3137.
Score: 0.003
-
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir. Antivir Ther. 2018; 23(2):139-148.
Score: 0.003
-
Osteoarticular bacterial infections are rare in HIV-infected patients. 14 cases found among 4,023 HIV-infected patients. Acta Orthop Scand. 1997 Dec; 68(6):554-8.
Score: 0.003
-
A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections. Eur J Clin Microbiol Infect Dis. 2018 Jan; 37(1):167-173.
Score: 0.002
-
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int J Antimicrob Agents. 2018 Feb; 51(2):244-248.
Score: 0.002
-
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial. J Antimicrob Chemother. 2017 07 01; 72(7):2055-2059.
Score: 0.002
-
Antibodies against a ß-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients. Sci Rep. 2017 06 02; 7(1):2722.
Score: 0.002
-
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). J Antimicrob Chemother. 2017 04 01; 72(4):1163-1171.
Score: 0.002
-
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series. Infection. 2017 Apr; 45(2):209-213.
Score: 0.002
-
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality. PLoS One. 2017; 12(2):e0170236.
Score: 0.002
-
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients. J Chemother. 2017 Oct; 29(5):299-307.
Score: 0.002
-
Predictors of Staphylococcus aureus pneumonia associated with human immunodeficiency virus infection. Respir Med. 1996 Oct; 90(9):531-7.
Score: 0.001
-
[Methionine Se 75 in hepatic scintigraphic diagnosis]. Arch Maragliano Patol Clin. 1976; 32:19-36.
Score: 0.000